Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression

Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression

SARS-CoV-2 infection causes a wide spectrum of disease severity. Identifying the immunological characteristics of severe disease and the risk factors for their development are important in the management of COVID-19. This study aimed to identify and rank clinical and immunological features associate...

Full description

Bibliographic Details
Main Authors: Liam Townsend, Adam H. Dyer, Aifric Naughton, Sultan Imangaliyev, Jean Dunne, Rachel Kiersey, Dean Holden, Aoife Mooney, Deirdre Leavy, Katie Ridge, Jamie Sugrue, Mubarak Aldoseri, Jo Hannah Kelliher, Martina Hennessy, Declan Byrne, Paul Browne, Christopher L. Bacon, Catriona Doyle, Ruth O’Riordan, Anne-Marie McLaughlin, Ciaran Bannan, Ignacio Martin-Loeches, Arthur White, Rachel M. McLoughlin, Colm Bergin, Nollaig M. Bourke, Cliona O’Farrelly, Niall Conlon, Clíona Ní Cheallaigh
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Heliyon
Subjects:
COVID-19
Immune phenotype
Neutrophil maturity
Machine learning
Biomarkers
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844022005187

Internet

http://www.sciencedirect.com/science/article/pii/S2405844022005187

Similar Items